rheumatology
Public Health

News in brief: Biosimilar prescribing lags in Australia; MSK multimorbidities common; Septic arthritis in Aussie kids

Australia lags behind Europe on biosimilar prescribing Prescribing of biosimilars for rheumatoid arthritis has shot ahead in Europe but lags in Australia, according to a 2020 survey by pharmaceutical analysts GlobalData. It showed that in Europe the number of physicians prescribing biosimilars for at least 75% of their RA patients increased from 48% to 63% ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic